The statistical genetics and pharmacogenomics research group focus on developing and applying methodology for the analysis of genetic data across a range of study designs, with the ultimate aims of improving our understanding of susceptibility to complex diseases as well as their diagnosis, prognosis and prevention, as well as identifying predictors of treatment response.